Latest Breaking News On - Clear cell renal carcinoma - Page 1 : comparemela.com

New PET Agent Enables Same-Day Imaging for Kidney Cancer

New PET Agent Enables Same-Day Imaging for Kidney Cancer
miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.

United statesMemorial sloan kettering cancer centerNew yorkJonathan wessenIvana galeticSolen pichereauOlena vlasyukDarrenr feldmanBen tranMichaels hofmanMichael hofmanAnna pokorskaMohammadb haskaliSir peter maccallum department of oncologyUniversity of melbourneDebiopharm international

New PET agent provides same-day imaging for clear cell renal cell carcinoma patients

New PET agent provides same-day imaging for clear cell renal cell carcinoma patients
medicalxpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medicalxpress.com Daily Mail and Mail on Sunday newspapers.

Michaels hofmanMichael hofmanPeter maccallum cancer centreJournal of nuclear medicineNuclear medicineProvides exceptional same day imagingClear cell renal carcinoma patientsProfessor michael hofmanFirst in human safetyCarbonic anhydraseTargeting peptideClear cell renal carcinoma

Dr Srour on the Safety and Efficacy of the Allogeneic CAR T-Cell Therapy CTX130 in Advanced ccRCC

Samer A. Srour, MB ChB, MS, discusses efficacy and safety data for the allogeneic CAR T-cell therapy CTX130 in advanced clear cell renal cell carcinoma.

United statesSamera srourUniversity of texas md anderson cancer centerDepartment of stem cell transplantationDivision of cancer medicineStem cell transplantationCancer medicineCancer centerB chbClear cell renal carcinoma

First-Line Treatments for Advanced Clear Cell RCC

A panel of medical oncologists who specialize in renal cell carcinoma (RCC) introduce themselves and discuss the first-line treatment landscape and risk stratification of clear cell RCC.

Advanced renal cell carcinomaLine treatmentsAdvanced clear cellRenal cell carcinomaAdvanced rccClear cell renal carcinomaNon clear cell renal carcinomaIo tkiRisk stratification

Subcutaneous Nivolumab Provides Clinical Equipoise to Standard IV Dosing in ccRCC

Subcutaneous nivolumab coformulated with rHuPH20 demonstrated noninferiority of PK exposures vs intravenous nivolumab in metastatic ccRCC.

New yorkUnited statesSaby georgeJacobs school of medicineNetwork clinical trialsRoswell park comprehensive cancer centerUniversity of buffaloBiomedical sciencesJacobs schoolSouth americaNivolumab noninferiority of exposuresIntravenous nivolumabIv nivolumabSubcutaneous nivolumab2024 genitourinary cancers symposiumPhase 3 checkmate 67t trial